CPDI-02 Increases Protection Against MRSA Infections in Mice
Author Information
Author(s): Stewart Jason P., Sandall Caleb M., Parriott Jacob E., Curran Stephen M., McCulloh Russell J., Ronning Donald R., Phillips Joy A., Schroeder Robin, Neel Christy, Lechtenberg Kelly F., Cohen Samuel M., Alnouti Yazen, Daria Sohel, Smith D. David, Vetro Joseph A., Casolaro Vincenzo
Primary Institution: University of Nebraska Medical Center
Hypothesis
Does treatment with CPDI-02 increase curative protection against subcutaneous infection with CA-MRSA?
Conclusion
Single early-stage IM treatment with CPDI-02 may increase curative protection against infections caused by CA-MRSA.
Supporting Evidence
- Repeat IM treatment with CPDI-02 decreased maximum abscess surface area by 58%.
- Single IM treatment at 6 h post-challenge was as effective as repeat treatment.
- CPDI-02 was tolerated at doses between 130 and 170 mg/kg.
Takeaway
Giving a special treatment called CPDI-02 to mice helps them fight off a bad germ that can cause skin infections.
Methodology
Female CD-1 mice were infected with CA-MRSA and treated with CPDI-02 via different routes to assess abscess size and infection resolution.
Potential Biases
Potential bias in treatment administration and measurement of outcomes.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Healthy female outbred CD-1 mice, aged 4-6 weeks.
Statistical Information
P-Value
0.0052
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website